08:00 , Mar 29, 2004 |  BioCentury  |  Strategy

All that Jazz . . .

All that Jazz . . . Company Raised Date Focus Investors Jazz $250.0 3/24/04 Neurology, cancer, endocrine Kohlberg Kravis Roberts; Prospect Venture Partners; Versant Ventures; Beecken Petty O'Keefe; Golden Gate Capital; Thoma Cressey Equity Partners;...
08:00 , Dec 3, 2001 |  BC Week In Review  |  Company News

Incyte Genomics Inc. board of directors update

Incyte Genomics Inc. (INCY), Palo Alto, Calif.   Business: Genomics   Departed: Randy Scott, as chairman   Appointed: Julian Baker, managing partner of Baker/Tisch Investments  ...
08:00 , Nov 7, 2001 |  BC Extra  |  Financial News

Ambit raises $10 million

Ambit Biosciences (San Diego, Calif.), which is using its ProteomeScan chemistry-directed technology for drug discovery, raised $10 million in private financing. Investors included Forward Ventures; Perseus-Soros Biopharmaceutical Fund; Avalon Ventures; and Baker-Tisch Investments....
07:00 , Oct 1, 2001 |  BioCentury  |  Finance

Ebb & Flow

Telik (TELK) sold the first underwritten deal since the terrorist attacks on Sept. 11, raising $26 million through the sale of 4 million shares at $6.50 in a follow-on. However, investors shouldn't read too much...
07:00 , Sep 27, 2001 |  BC Extra  |  Financial News

7TM Pharma raises $15 million

7TM Pharma raised $15 million in a series A venture round through Index Ventures; Lombard Odier; Novo A/S; Baker/Tisch Investments; and Dansk Innovationsinvestering. 7TM (Copenhagen, Denmark) is discovering drugs targeting from G protein-coupled receptors, also...
07:00 , Jun 7, 2001 |  BC Extra  |  Financial News

Cellegy raises $15.4 million

CLGY raised $15.4 million through the sale of 2.7 million shares at $5.70 to a group of investors including Baker/Tisch Investments; GMT Capital; OrbiMed Advisors; SAFECO Asset Management; First Manhattan Co. JALAA Equities; and Knott...
07:00 , Oct 3, 2000 |  BC Extra  |  Financial News

Cellegy raises $11.6 million

CLGY raised $11.6 million in a private placement of 1.5 million shares at $7.733. Investors included Baker/Tisch Investments; Capital Research & Management; and Framlington.CLGY is in Phase III testing of its Tostrex testosterone gel to...
07:00 , Sep 14, 2000 |  BC Extra  |  Financial News

Senomyx raises $10 million

Senomyx (La Jolla, Calif.) raised $10 million in a private round. Investors included Alejandro Zaffaroni; Baker Tisch Investments; Bay City Capital; Domain Associates; Prospect Ventures; Kingsbury Capital Partners; and Rho Management. Senomyx is developing products...